Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Asset Writedowns and Impairment (2022)

Vycor Medical (VYCO) has disclosed Asset Writedowns and Impairment for 1 consecutive years, with $4155.0 as the latest value for Q4 2022.

  • Quarterly Asset Writedowns and Impairment changed N/A to $4155.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $15515.0 through Dec 2022, changed N/A year-over-year, with the annual reading at $2690.0 for FY2025, 20.3% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2022 was $4155.0 at Vycor Medical, up from $2700.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $5960.0 in Q1 2022, with the low at $2700.0 in Q2 2022.